As of 2026-06-09, the Relative Valuation of Olema Pharmaceuticals Inc (OLMA) is (33.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.96 USD, the upside of Olema Pharmaceuticals Inc based on Relative Valuation is -438.9%.
The range of the Relative Valuation is (31.81) - (34.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 23.9x | 20.6x |
| Forward P/E multiples | 19.2x - 21.1x | 20.2x |
| Fair Price | (31.81) - (34.96) | (33.76) |
| Upside | -419.4% - -451.0% | -438.9% |
| Date | P/E |
| 2026-06-05 | -6.22 |
| 2026-06-04 | -6.45 |
| 2026-06-03 | -6.34 |
| 2026-06-02 | -6.45 |
| 2026-06-01 | -7.67 |
| 2026-05-29 | -7.96 |
| 2026-05-28 | -7.70 |
| 2026-05-27 | -7.79 |
| 2026-05-26 | -8.18 |
| 2026-05-22 | -8.26 |
| 2026-05-21 | -8.49 |
| 2026-05-20 | -8.43 |
| 2026-05-19 | -7.91 |
| 2026-05-18 | -7.79 |
| 2026-05-15 | -8.20 |
| 2026-05-14 | -8.34 |
| 2026-05-13 | -8.20 |
| 2026-05-12 | -8.43 |
| 2026-05-11 | -8.97 |
| 2026-05-08 | -8.99 |
| 2026-05-07 | -9.13 |
| 2026-05-06 | -9.17 |
| 2026-05-05 | -8.84 |
| 2026-05-04 | -8.83 |
| 2026-05-01 | -8.64 |
| 2026-04-30 | -8.70 |
| 2026-04-29 | -8.53 |
| 2026-04-28 | -8.81 |
| 2026-04-27 | -9.23 |
| 2026-04-24 | -9.37 |
| 2026-04-23 | -9.26 |
| 2026-04-22 | -9.80 |
| 2026-04-21 | -10.04 |
| 2026-04-20 | -10.01 |
| 2026-04-17 | -10.15 |
| 2026-04-16 | -9.95 |
| 2026-04-15 | -9.95 |
| 2026-04-14 | -9.84 |
| 2026-04-13 | -9.61 |
| 2026-04-10 | -9.72 |
| 2026-04-09 | -10.04 |
| 2026-04-08 | -9.47 |
| 2026-04-07 | -9.20 |
| 2026-04-06 | -9.16 |
| 2026-04-02 | -9.09 |
| 2026-04-01 | -9.13 |
| 2026-03-31 | -9.00 |
| 2026-03-30 | -8.10 |
| 2026-03-27 | -8.25 |
| 2026-03-26 | -8.52 |